Veterinary Medicines

Rispoval Lactovac C vakcina A.U.V.

Authorised
  • Bovine rotavirus, strain 1005/78, Inactivated
  • Bovine rotavirus, strain Holland, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
Download as PDF

Product identification

Medicine name:
Rispoval Lactovac C vakcina A.U.V.
Active substance:
  • Bovine rotavirus, strain 1005/78, Inactivated
  • Bovine rotavirus, strain Holland, Inactivated
  • Bovine coronavirus, strain 800, Inactivated
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
Target species:
  • Cattle
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine rotavirus, strain 1005/78, Inactivated
    7.40
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Bovine rotavirus, strain Holland, Inactivated
    7.00
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Bovine coronavirus, strain 800, Inactivated
    5.80
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)/dose
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5 and F41), strain S1091/83, Inactivated
    250.00
    haemagglutinating units
    /
    1.00
    unit(s)/dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."